Showing results (191-200 of 217) with videos related to
Sort By:
Pageof 22
Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.Inflammatory Bowel Diseases|December 20, 2007
No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohortsCarsten Büning, Hartmut H-J Schmidt, Tamás Molnár, et al.Therapeutic Advances in Gastroenterology|October 3, 2022
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel diseaseFarhad Peerani, Makayla Watt, Kathleen P Ismond, et al.Journal of the Canadian Association of Gastroenterology|December 5, 2022
Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort StudyCynthia H Seow, Stephanie Coward, Karen I Kroeker, et al.Gastroenterology|December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseJulián Panés, Damián García-Olmo, Gert Van Assche, et al.Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicineUri Kopylov, Bram Verstockt, Urko M Marigorta, et al.Inflammatory Bowel Diseases|August 29, 2009
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitisDaniel C Baumgart, Stephan R Targan, Axel U Dignass, et al.Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological ConsiderationsNurulamin M Noor, Marco Daperno, Jan de Laffolie, et al.Journal of Crohn'S & Colitis|August 12, 2025
Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitationsAlaa El-Hussuna, Gianluca Pellino, Alessandra Soriano, et al.Pageof 22